Not manufactured urgency - calendar urgency
Ozempic is not FDA-approved for the treatment of prediabetes (e.g., HbA1c or A1C of 5.76.4%)
8 Future directions The advancement of GLP-1 receptor agonists is progressing towards more refined treatment strategies, with tirzepatide at the forefront of research as a dual GIP/GLP-1 receptor agonist (Nauck and DAlessio 2022)
These therapeutic errors may lead to an increase in calls to poison control centers and emergency department visits related to medication errors nationwide
Adjustment Is Not Always Linear A patient can feel better for several days and then notice symptoms again
Townsend Letter 8690 James SJ, Rose S, Melnyk S, Jernigan S, Blossom S, Pavliv O, Gaylor DW (2009) Cellular and mitochondrial glutathione redox imbalance in lymphoblastoid cells derived from children with autism